{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:15:45Z","timestamp":1791000945523,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T00:00:00Z","timestamp":1571961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T00:00:00Z","timestamp":1571961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Diabetic cardiomyopathy is one of the main causes of heart failure and death in patients with diabetes. There are no effective approaches to preventing its development in the clinic. Long noncoding RNAs (lncRNA) are increasingly recognized as important molecular players in cardiovascular disease. Herein we investigated the profiling of cardiac lncRNA and mRNA expression in type 2 diabetic db\/db mice with and without early diabetic cardiomyopathy. We found that db\/db mice developed cardiac hypertrophy with normal cardiac function at 6 weeks of age but with a decreased diastolic function at 20 weeks of age. LncRNA and mRNA transcripts were remarkably different in 20-week-old db\/db mouse hearts compared with both nondiabetic and diabetic controls. Overall 1479 lncRNA transcripts and 1109 mRNA transcripts were aberrantly expressed in 6- and 20-week-old db\/db hearts compared with nondiabetic controls. The lncRNA-mRNA co-expression network analysis revealed that 5 deregulated lncRNAs having maximum connections with differentially expressed mRNAs were BC038927, G730013B05Rik, 2700054A10Rik, AK089884, and Daw1. Bioinformatics analysis revealed that these 5 lncRNAs are closely associated with membrane depolarization, action potential conduction, contraction of cardiac myocytes, and actin filament-based movement of cardiac cells. This study profiles differently expressed lncRNAs in type 2 mice with and without early diabetic cardiomyopathy and identifies BC038927, G730013B05Rik, 2700054A10Rik, AK089884, and Daw1 as the core lncRNA with high significance in diabetic cardiomyopathy.<\/jats:p>","DOI":"10.1038\/s41598-019-51872-9","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T18:34:30Z","timestamp":1572028470000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Genome-wide differential expression profiling of lncRNAs and mRNAs associated with early diabetic cardiomyopathy"],"prefix":"10.1038","volume":"9","author":[{"given":"Tarun","family":"Pant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Dhanasekaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1387-7058","authenticated-orcid":false,"given":"Edward B.","family":"Thorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Forbess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeljko J.","family":"Bosnjak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7045-0846","authenticated-orcid":false,"given":"Zhi-Dong","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,25]]},"reference":[{"key":"51872_CR1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrendo.2017.151","volume":"14","author":"Y Zheng","year":"2018","unstructured":"Zheng, Y., Ley, S. H. & Hu, F. B. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol 14, 88\u201398 (2018).","journal-title":"Nat Rev Endocrinol"},{"key":"51872_CR2","doi-asserted-by":"publisher","first-page":"e294","DOI":"10.1161\/CIR.0000000000000691","volume":"140","author":"SM Dunlay","year":"2019","unstructured":"Dunlay, S. M. et al. Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC\/AHA\/HFSA heart failure guideline update. Circulation 140, e294\u2013e324 (2019).","journal-title":"Circulation"},{"key":"51872_CR3","doi-asserted-by":"publisher","first-page":"e191540","DOI":"10.1001\/jamanetworkopen.2019.1540","volume":"2","author":"C Sabanayagam","year":"2019","unstructured":"Sabanayagam, C. et al. Association of Diabetic Retinopathy and Diabetic Kidney Disease With All-Cause and Cardiovascular Mortality in a Multiethnic Asian Population. JAMA Netw Open 2, e191540 (2019).","journal-title":"JAMA Netw Open"},{"key":"51872_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12872-018-0939-5","volume":"18","author":"T Pant","year":"2018","unstructured":"Pant, T. et al. Current status and strategies of long noncoding RNA research for diabetic cardiomyopathy. BMC Cardiovasc Disord 18, 197 (2018).","journal-title":"BMC Cardiovasc Disord"},{"key":"51872_CR5","doi-asserted-by":"crossref","unstructured":"Parim, B., Sathibabu Uddandrao, V. V. & Saravanan, G. Diabetic cardiomyopathy: molecular mechanisms, detrimental effects of conventional treatment, and beneficial effects of natural therapy. Heart Fail Rev (2018).","DOI":"10.1007\/s10741-018-9749-1"},{"key":"51872_CR6","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","volume":"122","author":"G Jia","year":"2018","unstructured":"Jia, G., Hill, M. A. & Sowers, J. R. Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity. Circ Res 122, 624\u2013638 (2018).","journal-title":"Circ Res"},{"key":"51872_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13098-017-0219-z","volume":"9","author":"A Marcinkiewicz","year":"2017","unstructured":"Marcinkiewicz, A., Ostrowski, S. & Drzewoski, J. Can the onset of heart failure be delayed by treating diabetic cardiomyopathy? Diabetol Metab Syndr 9, 21 (2017).","journal-title":"Diabetol Metab Syndr"},{"key":"51872_CR8","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1042\/CS20040057","volume":"107","author":"SA Hayat","year":"2004","unstructured":"Hayat, S. A., Patel, B., Khattar, R. S. & Malik, R. A. Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. Clin Sci (Lond) 107, 539\u2013557 (2004).","journal-title":"Clin Sci (Lond)"},{"key":"51872_CR9","doi-asserted-by":"publisher","first-page":"e3056","DOI":"10.1002\/dmrr.3056","volume":"34","author":"C Ma","year":"2018","unstructured":"Ma, C. et al. Long noncoding RNAs: A new player in the prevention and treatment of diabetic cardiomyopathy? Diabetes Metab Res Rev 34, e3056 (2018).","journal-title":"Diabetes Metab Res Rev"},{"key":"51872_CR10","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1126\/science.1231776","volume":"338","author":"JT Lee","year":"2012","unstructured":"Lee, J. T. Epigenetic regulation by long noncoding RNAs. Science 338, 1435\u20131439 (2012).","journal-title":"Science"},{"key":"51872_CR11","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1152\/physrev.00041.2015","volume":"96","author":"J Beermann","year":"2016","unstructured":"Beermann, J., Piccoli, M. T., Viereck, J. & Thum, T. Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches. Physiol Rev 96, 1297\u20131325 (2016).","journal-title":"Physiol Rev"},{"key":"51872_CR12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cell.2018.01.011","volume":"172","author":"F Kopp","year":"2018","unstructured":"Kopp, F. & Mendell, J. T. Functional Classification and Experimental Dissection of Long Noncoding RNAs. Cell 172, 393\u2013407 (2018).","journal-title":"Cell"},{"key":"51872_CR13","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3390\/cells3030883","volume":"3","author":"M Kataoka","year":"2014","unstructured":"Kataoka, M. & Wang, D. Z. Non-Coding RNAs Including miRNAs and lncRNAs in Cardiovascular Biology and Disease. Cells 3, 883\u2013898 (2014).","journal-title":"Cells"},{"key":"51872_CR14","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1161\/CIRCRESAHA.116.310152","volume":"120","author":"S Haemmig","year":"2017","unstructured":"Haemmig, S. & Feinberg, M. W. Targeting LncRNAs in Cardiovascular Disease: Options and Expeditions. Circ Res 120, 620\u2013623 (2017).","journal-title":"Circ Res"},{"key":"51872_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1161\/CIRCRESAHA.117.311802","volume":"122","author":"T Sallam","year":"2018","unstructured":"Sallam, T., Sandhu, J. & Tontonoz, P. Long Noncoding RNA Discovery in Cardiovascular Disease: Decoding Form to Function. Circ Res 122, 155\u2013166 (2018).","journal-title":"Circ Res"},{"key":"51872_CR16","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.ijcard.2015.10.019","volume":"202","author":"M Zhang","year":"2016","unstructured":"Zhang, M., Gu, H., Chen, J. & Zhou, X. Involvement of long noncoding RNA MALAT1 in the pathogenesis of diabetic cardiomyopathy. Int J Cardiol 202, 753\u2013755 (2016).","journal-title":"Int J Cardiol"},{"key":"51872_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S0026-0495(00)90588-2","volume":"49","author":"K Kobayashi","year":"2000","unstructured":"Kobayashi, K. et al. The db\/db mouse, a model for diabetic dyslipidemia: molecular characterization and effects of Western diet feeding. Metabolism 49, 22\u201331 (2000).","journal-title":"Metabolism"},{"key":"51872_CR18","doi-asserted-by":"publisher","first-page":"e002424","DOI":"10.1161\/CIRCHEARTFAILURE.115.002424","volume":"9","author":"SL Baumgardt","year":"2016","unstructured":"Baumgardt, S. L. et al. Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia\/Reperfusion Injury in Obese Type 2 Diabetic Mice. Circ Heart Fail 9, e002424 (2016).","journal-title":"Circ Heart Fail"},{"key":"51872_CR19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1748-1716.2010.02102.x","volume":"200","author":"A Daniels","year":"2010","unstructured":"Daniels, A. et al. Impaired cardiac functional reserve in type 2 diabetic db\/db mice is associated with metabolic, but not structural, remodelling. Acta Physiol (Oxf) 200, 11\u201322 (2010).","journal-title":"Acta Physiol (Oxf)"},{"key":"51872_CR20","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/379632a0","volume":"379","author":"GH Lee","year":"1996","unstructured":"Lee, G. H. et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature 379, 632\u2013635 (1996).","journal-title":"Nature"},{"key":"51872_CR21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2174\/1573399810666140508121012","volume":"10","author":"B Wang","year":"2014","unstructured":"Wang, B., Chandrasekera, P. C. & Pippin, J. J. Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes. Curr Diabetes Rev 10, 131\u2013145 (2014).","journal-title":"Curr Diabetes Rev"},{"key":"51872_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2337\/diacare.24.1.5","volume":"24","author":"P Poirier","year":"2001","unstructured":"Poirier, P., Bogaty, P., Garneau, C., Marois, L. & Dumesnil, J. G. Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care 24, 5\u201310 (2001).","journal-title":"Diabetes Care"},{"key":"51872_CR23","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1111\/pme.12845","volume":"16","author":"M Yang","year":"2015","unstructured":"Yang, M., Qian, C. & Liu, Y. Suboptimal Treatment of Diabetic Peripheral Neuropathic Pain in the United States. Pain Med 16, 2075\u20132083 (2015).","journal-title":"Pain Med"},{"key":"51872_CR24","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/nm.4179","volume":"22","author":"Z Wang","year":"2016","unstructured":"Wang, Z. et al. The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy. Nat Med 22, 1131\u20131139 (2016).","journal-title":"Nat Med"},{"key":"51872_CR25","doi-asserted-by":"publisher","first-page":"326ra322","DOI":"10.1126\/scitranslmed.aaf1475","volume":"8","author":"J Viereck","year":"2016","unstructured":"Viereck, J. et al. Long noncoding RNA Chast promotes cardiac remodeling. Sci Transl Med 8, 326ra322 (2016).","journal-title":"Sci Transl Med"},{"key":"51872_CR26","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1161\/CIRCRESAHA.117.310624","volume":"121","author":"MT Piccoli","year":"2017","unstructured":"Piccoli, M. T. et al. Inhibition of the Cardiac Fibroblast-Enriched lncRNA Meg3 Prevents Cardiac Fibrosis and Diastolic Dysfunction. Circ Res 121, 575\u2013583 (2017).","journal-title":"Circ Res"},{"key":"51872_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02280-y","volume":"9","author":"CY Liu","year":"2018","unstructured":"Liu, C. Y. et al. LncRNA CAIF inhibits autophagy and attenuates myocardial infarction by blocking p53-mediated myocardin transcription. Nat Commun 9, 29 (2018).","journal-title":"Nat Commun"},{"key":"51872_CR28","doi-asserted-by":"crossref","unstructured":"Zhou, L.Y. et al. The circular RNA ACR attenuates myocardial ischemia\/reperfusion injury by suppressing autophagy via modulation of the Pink1\/FAM65B pathway. Cell Death Differ (2018).","DOI":"10.1038\/s41418-018-0206-4"},{"key":"51872_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/srep36340","volume":"6","author":"X Li","year":"2016","unstructured":"Li, X. et al. lncRNA H19\/miR-675 axis regulates cardiomyocyte apoptosis by targeting VDAC1 in diabetic cardiomyopathy. Sci Rep 6, 36340 (2016).","journal-title":"Sci Rep"},{"key":"51872_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.321","volume":"8","author":"X Zhou","year":"2017","unstructured":"Zhou, X. et al. lncRNA MIAT functions as a competing endogenous RNA to upregulate DAPK2 by sponging miR-22-3p in diabetic cardiomyopathy. Cell Death Dis 8, e2929 (2017).","journal-title":"Cell Death Dis"},{"key":"51872_CR31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1475-2840-13-77","volume":"13","author":"JN Adams","year":"2014","unstructured":"Adams, J. N. et al. Analysis of common and coding variants with cardiovascular disease in the Diabetes Heart Study. Cardiovasc Diabetol 13, 77 (2014).","journal-title":"Cardiovasc Diabetol"},{"key":"51872_CR32","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s11892-017-0906-z","volume":"17","author":"E Dahlstrom","year":"2017","unstructured":"Dahlstrom, E. & Sandholm, N. Progress in Defining the Genetic Basis of Diabetic Complications. Curr Diab Rep 17, 80 (2017).","journal-title":"Curr Diab Rep"},{"key":"51872_CR33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.gde.2018.01.002","volume":"50","author":"N Sandholm","year":"2018","unstructured":"Sandholm, N. & Groop, P. H. Genetic basis of diabetic kidney disease and other diabetic complications. Curr Opin Genet Dev 50, 17\u201324 (2018).","journal-title":"Curr Opin Genet Dev"},{"key":"51872_CR34","doi-asserted-by":"publisher","first-page":"e0192696","DOI":"10.1371\/journal.pone.0192696","volume":"13","author":"N Mukhopadhyay","year":"2018","unstructured":"Mukhopadhyay, N., Noble, J. A., Govil, M., Marazita, M. L. & Greenberg, D. A. Identifying genetic risk loci for diabetic complications and showing evidence for heterogeneity of type 1 diabetes based on complications risk. PLoS One 13, e0192696 (2018).","journal-title":"PLoS One"},{"key":"51872_CR35","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.cell.2009.02.006","volume":"136","author":"CP Ponting","year":"2009","unstructured":"Ponting, C. P., Oliver, P. L. & Reik, W. Evolution and functions of long noncoding RNAs. Cell 136, 629\u2013641 (2009).","journal-title":"Cell"},{"key":"51872_CR36","first-page":"925","volume":"10","author":"L Ma","year":"2013","unstructured":"Ma, L., Bajic, V. B. & Zhang, Z. On the classification of long non-coding RNAs. RNA Biol 10, 925\u2013933 (2013).","journal-title":"RNA Biol"},{"key":"51872_CR37","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.3390\/ijms16023251","volume":"16","author":"VE Villegas","year":"2015","unstructured":"Villegas, V. E. & Zaphiropoulos, P. G. Neighboring gene regulation by antisense long non-coding RNAs. Int J Mol Sci 16, 3251\u20133266 (2015).","journal-title":"Int J Mol Sci"},{"key":"51872_CR38","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.molcel.2011.08.018","volume":"43","author":"KC Wang","year":"2011","unstructured":"Wang, K. C. & Chang, H. Y. Molecular mechanisms of long noncoding RNAs. Mol Cell 43, 904\u2013914 (2011).","journal-title":"Mol Cell"},{"issue":"3","key":"51872_CR39","doi-asserted-by":"publisher","first-page":"e00337","DOI":"10.1042\/BSR20150278","volume":"36","author":"X. Qu","year":"2016","unstructured":"Qu, X. et al. Expression signature of lncRNAs and their potential roles in cardiac fibrosis of post-infarct mice. Biosci Rep 36 (2016).","journal-title":"Bioscience Reports"},{"key":"51872_CR40","doi-asserted-by":"publisher","first-page":"e0187967","DOI":"10.1371\/journal.pone.0187967","volume":"12","author":"RH Al-Rifai","year":"2017","unstructured":"Al-Rifai, R. H., Pearson, F., Critchley, J. A. & Abu-Raddad, L. J. Association between diabetes mellitus and active tuberculosis: A systematic review and meta-analysis. PLoS One 12, e0187967 (2017).","journal-title":"PLoS One"},{"key":"51872_CR41","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.3389\/fmicb.2017.02368","volume":"8","author":"MJ Blumenthal","year":"2017","unstructured":"Blumenthal, M. J., Ujma, S., Katz, A. A. & Schafer, G. The Role of Type 2 Diabetes for the Development of Pathogen-Associated Cancers in the Face of the HIV\/AIDS Epidemic. Front Microbiol 8, 2368 (2017).","journal-title":"Front Microbiol"},{"key":"51872_CR42","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.3748\/wjg.v23.i9.1697","volume":"23","author":"AC Desbois","year":"2017","unstructured":"Desbois, A. C. & Cacoub, P. Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review. World J Gastroenterol 23, 1697\u20131711 (2017).","journal-title":"World J Gastroenterol"},{"key":"51872_CR43","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.metabol.2018.10.013","volume":"92","author":"A Lopez-Suarez","year":"2019","unstructured":"Lopez-Suarez, A. Burden of cancer attributable to obesity, type 2 diabetes and associated risk factors. Metabolism 92, 136\u2013146 (2019).","journal-title":"Metabolism"},{"key":"51872_CR44","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1124\/jpet.106.111351","volume":"319","author":"ZD Ge","year":"2006","unstructured":"Ge, Z. D. et al. Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5\u2019-N-methylcarboxamide] reduces ischemia\/reperfusion injury in mice by activating the A3 adenosine receptor. J Pharmacol Exp Ther 319, 1200\u20131210 (2006).","journal-title":"J Pharmacol Exp Ther"},{"key":"51872_CR45","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/ALN.0000000000001926","volume":"128","author":"ZD Ge","year":"2018","unstructured":"Ge, Z. D. et al. Failure of Isoflurane Cardiac Preconditioning in Obese Type 2 Diabetic Mice Involves Aberrant Regulation of MicroRNA-21, Endothelial Nitric-oxide Synthase, and Mitochondrial Complex I. Anesthesiology 128, 117\u2013129 (2018).","journal-title":"Anesthesiology"},{"key":"51872_CR46","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1113\/expphysiol.2008.046474","volume":"94","author":"D Senador","year":"2009","unstructured":"Senador, D., Kanakamedala, K., Irigoyen, M. C., Morris, M. & Elased, K. M. Cardiovascular and autonomic phenotype of db\/db diabetic mice. Exp Physiol 94, 648\u2013658 (2009).","journal-title":"Exp Physiol"},{"key":"51872_CR47","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.yjmcc.2010.01.018","volume":"49","author":"ZD Ge","year":"2010","unstructured":"Ge, Z. D., van der Hoeven, D., Maas, J. E., Wan, T. C. & Auchampach, J. A. A(3) adenosine receptor activation during reperfusion reduces infarct size through actions on bone marrow-derived cells. J Mol Cell Cardiol 49, 280\u2013286 (2010).","journal-title":"J Mol Cell Cardiol"},{"key":"51872_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/srep27925","volume":"6","author":"HE Wu","year":"2016","unstructured":"Wu, H. E. et al. Cardiomyocyte GTP Cyclohydrolase 1 Protects the Heart Against Diabetic Cardiomyopathy. Sci Rep 6, 27925 (2016).","journal-title":"Sci Rep"},{"key":"51872_CR49","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/ALN.0b013e3181c4a607","volume":"112","author":"ZD Ge","year":"2010","unstructured":"Ge, Z. D. et al. Isoflurane postconditioning protects against reperfusion injury by preventing mitochondrial permeability transition by an endothelial nitric oxide synthase-dependent mechanism. Anesthesiology 112, 73\u201385 (2010).","journal-title":"Anesthesiology"},{"key":"51872_CR50","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1097\/ALN.0000000000000807","volume":"123","author":"S Qiao","year":"2015","unstructured":"Qiao, S. et al. MicroRNA-21 Mediates Isoflurane-induced Cardioprotection against Ischemia-Reperfusion Injury via Akt\/Nitric Oxide Synthase\/Mitochondrial Permeability Transition Pore Pathway. Anesthesiology 123, 786\u2013798 (2015).","journal-title":"Anesthesiology"},{"key":"51872_CR51","doi-asserted-by":"crossref","unstructured":"Pant, T. et al. Microarray analysis of long non-coding RNA and mRNA expression profiles in diabetic cardiomyopathy using human induced pluripotent stem cell-derived cardiomyocytes. Diab Vasc Dis Res, 1479164118813888 (2018).","DOI":"10.1096\/fasebj.2018.32.1_supplement.580.15"},{"key":"51872_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/srep21499","volume":"6","author":"C Dou","year":"2016","unstructured":"Dou, C. et al. Changing expression profiles of lncRNAs, mRNAs, circRNAs and miRNAs during osteoclastogenesis. Sci Rep 6, 21499 (2016).","journal-title":"Sci Rep"},{"key":"51872_CR53","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3389\/fnmol.2017.00454","volume":"10","author":"C Li","year":"2017","unstructured":"Li, C. et al. Profiling and Co-expression Network Analysis of Learned Helplessness Regulated mRNAs and lncRNAs in the Mouse Hippocampus. Front Mol Neurosci 10, 454 (2017).","journal-title":"Front Mol Neurosci"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-51872-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-51872-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-51872-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T19:30:57Z","timestamp":1721935857000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-51872-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,25]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["51872"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-51872-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,25]]},"assertion":[{"value":"11 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15345"}}